Cogent Solutions Group renews support of university research on molecular basis of hyaluronan action
Cogent Solutions Group has announced that it is funding further university research into the molecular basis of hyaluronan action. The studies, performed under the supervision of one of the global thought leaders in the molecular mechanism of hyaluronan signaling, are designed to add further to the body of knowledge concerning the relationship between hyaluronan signaling and skeletal health. Various indicia of skeletal health will be monitored as a function of oral hyaluronan supplementation, with a view toward establishing more firmly the molecular basis of hyaluronan action to maintain and improve skeletal health. Jim Smith, CEO of Cogent, had the following to say about the study-"With our support of this research, Cogent renews its commitment to be the world leader in elucidating the molecular mechanisms by which hyaluronan supplementation contributes to human and animal health."
